Results 81 to 90 of about 74,243 (234)

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

open access: yesVascular Health and Risk Management, 2009
R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology.
R Michael Kirchner, J Dawn Abbott
doaj  

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

open access: yesNew England Journal of Medicine, 2014
L. Mauri   +23 more
semanticscholar   +1 more source

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

open access: yesJournal of the American College of Cardiology, 2006
M. Joner   +9 more
semanticscholar   +1 more source

Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

open access: yesInternational Journal of Medical Sciences, 2011
Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD).
Davran Çiçek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Drug-eluting stent: a review and update [PDF]

open access: green, 2005
Thein Thein Htay, Ming W Liu
openalex   +1 more source

Promoting vascular healing using nanofibrous ticagrelor-eluting stents

open access: yesInternational Journal of Nanomedicine, 2018
Cheng-Hung Lee,1 Ming-Jer Hsieh,1 Kuo-Sheng Liu,2,3 Che-Wei Cheng,3 Shang-Hung Chang,1 Shih-Jung Liu,3,4 Chao-Jan Wang,5 Ming-Yi Hsu,5 Kuo-Chun Hung,1 Yung-Hsin Yeh,1 Wei-Jan Chen,1 I-Chang Hsieh,1 Jyuhn-Huarng Juang,6 Ming-Shien Wen1 1Division of ...
Lee CH   +13 more
doaj  

Home - About - Disclaimer - Privacy